MALIGNANT RHABDOID TUMOR
Clinical trials for MALIGNANT RHABDOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT RHABDOID TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT RHABDOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged t cells take on hard-to-treat cancers in new trial
Disease control Recruiting nowThis early-phase study tests a new type of immunotherapy for adults with solid tumors that have a specific marker called GPC3. The treatment involves taking a patient's own T cells, adding genes to help them recognize and attack cancer cells, and then giving them back. The study …
Matched conditions: MALIGNANT RHABDOID TUMOR
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
New CAR t therapy targets Hard-to-Treat childhood cancers
Disease control Recruiting nowThis early-stage trial tests a new type of immunotherapy for children and young adults with certain solid tumors that have come back or not responded to treatment. The therapy uses the patient's own immune cells, which are modified in a lab to better recognize and attack cancer c…
Matched conditions: MALIGNANT RHABDOID TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Engineered immune cells take on childhood cancers in new trial
Disease control Recruiting nowThis early-phase trial tests a new experimental treatment called CARE T cells for children and young adults with certain solid tumors (like liver cancer or Wilms tumor) that have returned or not responded to standard therapy. The treatment involves taking a patient's own immune c…
Matched conditions: MALIGNANT RHABDOID TUMOR
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 12, 2026 13:39 UTC